View in EDS

Characterisation of a cohort of opportunistically recruited patients with COVID-19 and approaches to patient stratification.

Saved in:
Bibliographic Details
Title: Characterisation of a cohort of opportunistically recruited patients with COVID-19 and approaches to patient stratification.
Authors: Shareef S; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK., Matthews E; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK., Dodds J; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK., Silverberg A; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK., Daly ME; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK., Ahmed W; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK., Bannard-Smith J; Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, M13 9WL, UK., Gethings LA; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.; Waters Corporation, Stamford Avenue, Altrincham Road, Wilmslow, Cheshire, SK9 4AX, UK.; School of Biosciences and Medicine, the University of Surrey, Guildford, Surrey, GU2 7XH, UK., King A; Waters Corporation, Stamford Avenue, Altrincham Road, Wilmslow, Cheshire, SK9 4AX, UK., Hughes C; Waters Corporation, Stamford Avenue, Altrincham Road, Wilmslow, Cheshire, SK9 4AX, UK., Fowler S; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, M23 9LT, UK., Felton T; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, M23 9LT, UK., Simpson A; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, M23 9LT, UK., Mills ENC; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK. clare.mills@surrey.ac.uk.; School of Biosciences and Medicine, the University of Surrey, Guildford, Surrey, GU2 7XH, UK. clare.mills@surrey.ac.uk.
Source: BMC infectious diseases [BMC Infect Dis] 2026 Mar 31; Vol. 26 (1). Date of Electronic Publication: 2026 Mar 31.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41917819
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Characterisation of a cohort of opportunistically recruited patients with COVID-19 and approaches to patient stratification.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shareef+S%22">Shareef S</searchLink>; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.<br /><searchLink fieldCode="AU" term="%22Matthews+E%22">Matthews E</searchLink>; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.<br /><searchLink fieldCode="AU" term="%22Dodds+J%22">Dodds J</searchLink>; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.<br /><searchLink fieldCode="AU" term="%22Silverberg+A%22">Silverberg A</searchLink>; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.<br /><searchLink fieldCode="AU" term="%22Daly+ME%22">Daly ME</searchLink>; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.<br /><searchLink fieldCode="AU" term="%22Ahmed+W%22">Ahmed W</searchLink>; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.<br /><searchLink fieldCode="AU" term="%22Bannard-Smith+J%22">Bannard-Smith J</searchLink>; Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, M13 9WL, UK.<br /><searchLink fieldCode="AU" term="%22Gethings+LA%22">Gethings LA</searchLink>; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.; Waters Corporation, Stamford Avenue, Altrincham Road, Wilmslow, Cheshire, SK9 4AX, UK.; School of Biosciences and Medicine, the University of Surrey, Guildford, Surrey, GU2 7XH, UK.<br /><searchLink fieldCode="AU" term="%22King+A%22">King A</searchLink>; Waters Corporation, Stamford Avenue, Altrincham Road, Wilmslow, Cheshire, SK9 4AX, UK.<br /><searchLink fieldCode="AU" term="%22Hughes+C%22">Hughes C</searchLink>; Waters Corporation, Stamford Avenue, Altrincham Road, Wilmslow, Cheshire, SK9 4AX, UK.<br /><searchLink fieldCode="AU" term="%22Fowler+S%22">Fowler S</searchLink>; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, M23 9LT, UK.<br /><searchLink fieldCode="AU" term="%22Felton+T%22">Felton T</searchLink>; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, M23 9LT, UK.<br /><searchLink fieldCode="AU" term="%22Simpson+A%22">Simpson A</searchLink>; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, M23 9LT, UK.<br /><searchLink fieldCode="AU" term="%22Mills+ENC%22">Mills ENC</searchLink>; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK. clare.mills@surrey.ac.uk.; School of Biosciences and Medicine, the University of Surrey, Guildford, Surrey, GU2 7XH, UK. clare.mills@surrey.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100968551%22">BMC infectious diseases</searchLink> [BMC Infect Dis] 2026 Mar 31; Vol. 26 (1). <i>Date of Electronic Publication: </i>2026 Mar 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100968551 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2334 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712334%22">14712334 </searchLink><i>NLM ISO Abbreviation: </i>BMC Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41917819
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12879-026-13070-7
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Characterisation of a cohort of opportunistically recruited patients with COVID-19 and approaches to patient stratification.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shareef S
      – PersonEntity:
          Name:
            NameFull: Matthews E
      – PersonEntity:
          Name:
            NameFull: Dodds J
      – PersonEntity:
          Name:
            NameFull: Silverberg A
      – PersonEntity:
          Name:
            NameFull: Daly ME
      – PersonEntity:
          Name:
            NameFull: Ahmed W
      – PersonEntity:
          Name:
            NameFull: Bannard-Smith J
      – PersonEntity:
          Name:
            NameFull: Gethings LA
      – PersonEntity:
          Name:
            NameFull: King A
      – PersonEntity:
          Name:
            NameFull: Hughes C
      – PersonEntity:
          Name:
            NameFull: Fowler S
      – PersonEntity:
          Name:
            NameFull: Felton T
      – PersonEntity:
          Name:
            NameFull: Simpson A
      – PersonEntity:
          Name:
            NameFull: Mills ENC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 03
              Text: 2026 Mar 31
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2334
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC infectious diseases
              Type: main
ResultId 1